Quality control is the day- to-day assessment of all compounding operations. This includes receipt of raw materials, preparation, storage, distribution, patient administration, and analytic testing of the finished product .
Aspect of management function that determines and implements the “quality policy”, i.e. the overall intention and direction of an organization regarding quality, as formally expressed and authorized by top management. The basic elements of quality management are:
— an appropriate infrastructure or “quality system”, encompassing the organizational structure, procedures, processes and resources;
— systematic actions necessary to ensure adequate confidence that a product (or service) will satisfy given requirements for quality. The totality of these actions is termed “quality assurance”. Within an organization, quality assurance serves as a management tool
READINGS
CONTENTS
Pharmaceutical Quality Management
COURSE SCHEDULE
Week |
Topics and Readings |
Dates |
1. |
Introduction (1&4), |
1st weak |
2. |
QUALITY CONTROL OF SOLID DOSAGE FORMS Physical tests: Hardness, Thickness, Diameter,(2 &3) |
2nd Weak
|
3. |
Friability, Disintegration, Weight Variation( USP &BP) |
3rd weak |
4. |
QUALITY CONTROL OF STERILE PRODUCTS (PARENTERALS): Pyrogen test for Parenteral and other sterile preparations (151, USP30 NF25, 85: USP30 NF25) |
4th Weak |
5. |
Sterility Test and Sterile section management, (71USP30 NF25) |
5th weak |
6. |
Leaker’s test, Clarity test, Assay for active Ingredient.(788, USP30 NF25) |
6th Weak |
7. |
QUALITY CONTROL OF SYRUPS, ELIXIRS, AND DISPERSE SYSTEM: Viscosity, its determination (911, USP30 NF25) |
7th weak |
8. |
Mid Term exams |
8th Weak |
9. |
Aapplications of viscosity in the Quality Control of Pharmaceuticals, Weight per ml and Assay of active Ingredient (911, USP30 NF25) |
9th weak |
10. |
QUALITY CONTROL OF SUPPOSITORIES: Dissolution test, Uniformity of weight, (711, USP30 NF25) |
10th Weak |
11. |
Assay of active Ingredient, Liquefaction time test and Breaking test. |
11th Weak |
12. |
QUALITY CONTROL OF SOLID DOSAGE FORMS Chemical tests: Content uniformity, Assay of active Ingredient. (2 &3) |
12th Weak |
13. |
STANDARDIZATION OF PHARMACEUTICALS: An understanding of quality assurance system adopted in pharmaceutical industry.( 1 &4) |
13th Weak |
14. |
Good Manufacturing Practices and Current Good Manufacturing Practices. (1&4) |
14th Weak |
15. |
Presentation |
15th Weak |
16. |
Final Term Examination |
16th Weak |
ASSESSMENT CRITERIA
Sessional: 20
Midterm exam: 30
Final exam: 50
RULES AND REGULATIONS